Synthetic Biologics, Inc. 4
4 · Synthetic Biologics, Inc. · Filed Jan 12, 2015
Insider Transaction Report
Form 4
Ballantyne Charles Evan
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Options
2015-01-08+200,000→ 200,000 totalExercise: $1.54From: 2015-01-08Exp: 2025-01-08→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]These options will vest quarterly on a pro rated basis over 36 consecutive months.